Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.39 |
| ▸ | BCL9 | O00512 | 1/20 | 0.35 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5662288 | 0.86 | ADRA1A (0.42) | MGLLBCL9CTNNB1KDM1AGAA | |
| SCHEMBL8174001 | 0.86 | ADRA1A (0.42) | MGLLBCL9CTNNB1KDM1AGAA | |
| SCHEMBL5658840 | 0.86 | ADRA1A (0.42) | MGLLBCL9CTNNB1KDM1AGAA | |
| SCHEMBL7747876 | 0.84 | MGLL (0.39) | MGLLKDM1AGAA | |
| SCHEMBL7747880 | 0.84 | MGLL (0.39) | MGLLKDM1AGAA | |
| SCHEMBL7995847 | 0.84 | MGLL (0.39) | MGLLKDM1AGAA | |
| SCHEMBL6953243 | 0.84 | MGLL (0.38) | MGLLCYP1A2CYP2D6FAAH | |
| SCHEMBL7966161 | 0.81 | MGLL (0.43) | MGLLCYP1A2CYP2D6FAAH | |
| SCHEMBL8173301 | 0.81 | MGLL (0.43) | MGLLCYP1A2CYP2D6FAAH | |
| SCHEMBL7972617 | 0.79 | ADRA1A (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6228870-B1 | BENIGN PROSTATIC HYPERPLASIA; REDUCTION OF HYPOTENSION SIDE EFFECT | MERCK & CO., INC. | 2001-05-08 | — | — | US | disclosed |